S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|American Red Cross to Participate in Cerus' IDE Study to Address Chikungunya and Dengue Blood Safety Risks|
|Cerus and Biomedica Foscama Group S.p.A. Enter Distribution Agreement for the INTERCEPT Blood System in Italy|
|U.S. FDA Accepts IDE Submission by Cerus Making the INTERCEPT Blood System Available to Address Chikungunya and Dengue Blood Safety Risks|
|Cerus Submits IDE Supplement to Make INTERCEPT Platelets Available Pre-Approval in U.S. Areas at Risk from Outbreaks of Chikungunya and Dengue|
|Cerus Announces Agreement With Kawasumi Laboratories for the Development of INTERCEPT Platelets Kits in Japan|
|Cerus Submits Compassionate Use IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma|
|Cerus to Present at the Morgan Stanley 2014 Global Health Care Conference on September 10, 2014|
|Cerus to Present at the Baird 2014 Health Care Conference on September 3, 2014|
|Cerus to Release Third Quarter 2014 Results on November 4, 2014|
|Cerus Corporation Reports Third Quarter 2014 Results|
Click above to view more mutual fund data and stats for cers - Cerus Corp.